VU6015929 is primarily used in neuroscience research to study the role of specific receptors in the brain. It acts as a selective antagonist, helping researchers understand the mechanisms underlying neurological disorders such as schizophrenia, Parkinson's disease, and addiction. By modulating receptor activity, it provides insights into potential therapeutic targets. Additionally, it is utilized in preclinical studies to evaluate the efficacy and safety of new drugs targeting these receptors. Its application extends to behavioral and pharmacological experiments, aiding in the development of novel treatments for central nervous system disorders.